Clinical Trial Update: Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating inhaled insulin for type 2 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Inhaled insulin (insulin inhalation powder) (insulin inhalation powder)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED